Literature DB >> 11409701

The -141C Ins/Del polymorphism of the dopamine D2 receptor gene is not associated with either migraine or Parkinson's disease.

S Maude1, J Curtin, G Breen, D Collier, G Russell, D Shaw, D S Clair.   

Abstract

Abnormalities in dopamine neurotransmission at the dopamine D2 receptor (DRD2) have been implicated in both migraine and Parkinson's disease. Positive associations have also been found between polymorphisms within the DRD2 gene and both of these conditions. The -141C Ins/Del polymorphism in the DRD2 receptor gene is a putative functional polymorphism. The purpose of this study was to determine whether it and any genes in linkage disequilibrium with this marker are involved in either of these conditions. We have compared the genotype and allele frequencies of the -141C Ins/Del polymorphism in 200 migraineurs and 260 Parkinson's disease cases with 464 controls. We have found no association between the receptor gene and either condition (P = 0.89 and P = 0.56 respectively). Our findings do not support the hypothesis that this polymorphism is involved in the aetiology of migraine or Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11409701     DOI: 10.1097/00041444-200103000-00010

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  9 in total

1.  Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility.

Authors:  Jayashri Ghosh; Sunil Pradhan; Balraj Mittal
Journal:  Neuromolecular Med       Date:  2012-08-09       Impact factor: 3.843

Review 2.  Migraine genetics.

Authors:  Esther Kors; Joost Haan; Michel Ferrari
Journal:  Curr Pain Headache Rep       Date:  2003-06

Review 3.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

4.  New genetic evidence for involvement of the dopamine system in migraine with aura.

Authors:  Unda Todt; Christian Netzer; Mohammad Toliat; Axel Heinze; Ingrid Goebel; Peter Nürnberg; Hartmut Göbel; Jan Freudenberg; Christian Kubisch
Journal:  Hum Genet       Date:  2009-01-17       Impact factor: 4.132

Review 5.  Update on the genetics of migraine.

Authors:  Miguel Estevez; Kathy L Gardner
Journal:  Hum Genet       Date:  2003-11-18       Impact factor: 4.132

6.  The primary headaches: genetics, epigenetics and a behavioural genetic model.

Authors:  Pasquale Montagna
Journal:  J Headache Pain       Date:  2008-03-15       Impact factor: 7.277

7.  Two-stage case-control association study of dopamine-related genes and migraine.

Authors:  Roser Corominas; Marta Ribases; Montserrat Camiña; Ester Cuenca-León; Julio Pardo; Susana Boronat; María-Jesús Sobrido; Bru Cormand; Alfons Macaya
Journal:  BMC Med Genet       Date:  2009-09-21       Impact factor: 2.103

8.  Family-based association analysis of functional VNTR polymorphisms in the dopamine transporter gene in migraine with and without aura.

Authors:  A Karwautz; S Campos de Sousa; A Konrad; H-E Zesch; G Wagner; A Zormann; C Wanner; G Breen; M Ray; C Kienbacher; S Natriashvili; D A Collier; C Wöber; C Wöber-Bingöl
Journal:  J Neural Transm (Vienna)       Date:  2007-08-10       Impact factor: 3.575

9.  Association Between Polymorphisms of DRD2, COMT, DBH, and MAO-A Genes and Migraine Susceptibility: A Meta-Analysis.

Authors:  Hu Chen; Chun-Xue Ji; Lian-Li Zhao; Xiang-Jun Kong; Xian-Tao Zeng
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.